Hongkun Wang

Hongkun Wang

Georgetown University

H-index: 35

North America-United States

About Hongkun Wang

Hongkun Wang, With an exceptional h-index of 35 and a recent h-index of 23 (since 2020), a distinguished researcher at Georgetown University, specializes in the field of statistics, biostatistics, survival analysis, cost and cost-effectiveness and quality-adjusted lifetime analysis, clinical trial.

His recent articles reflect a diverse array of research interests and contributions to the field:

Phase 1 Study of Hypofractionated Proton Beam Radiation Therapy in Adjuvant Pancreatic Cancer (PROTON-PANC)

TKIs beyond immunotherapy predict improved survival in advanced HCC

Bridging and downstaging with TACE in early and intermediate stage hepatocellular carcinoma: Predictors of receiving a liver transplant

A phase I dose-escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma: Interim update.

Phase II study of combination pembrolizumab and olaparib in patients with advanced cholangiocarcinoma: Interim results.

Molecular characterization of squamous cell carcinoma of the anal canal

A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies

Outcome of early and intermediate-stage hepatocellular carcinoma (HCC): A single institution experience at MGUH.

Hongkun Wang Information

University

Position

___

Citations(all)

5194

Citations(since 2020)

2433

Cited By

3792

hIndex(all)

35

hIndex(since 2020)

23

i10Index(all)

70

i10Index(since 2020)

48

Email

University Profile Page

Google Scholar

Hongkun Wang Skills & Research Interests

statistics

biostatistics

survival analysis

cost and cost-effectiveness and quality-adjusted lifetime analysis

clinical trial

Top articles of Hongkun Wang

Phase 1 Study of Hypofractionated Proton Beam Radiation Therapy in Adjuvant Pancreatic Cancer (PROTON-PANC)

International Journal of Radiation Oncology* Biology* Physics

2024/2/1

Benjamin A Weinberg
Benjamin A Weinberg

H-Index: 11

Hongkun Wang
Hongkun Wang

H-Index: 21

TKIs beyond immunotherapy predict improved survival in advanced HCC

Journal of Cancer Research and Clinical Oncology

2023/6

Xue Geng
Xue Geng

H-Index: 3

Hongkun Wang
Hongkun Wang

H-Index: 21

Bridging and downstaging with TACE in early and intermediate stage hepatocellular carcinoma: Predictors of receiving a liver transplant

Annals of Gastroenterological Surgery

2023/3

A phase I dose-escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma: Interim update.

2022/1/5

Phase II study of combination pembrolizumab and olaparib in patients with advanced cholangiocarcinoma: Interim results.

2022/1/5

Molecular characterization of squamous cell carcinoma of the anal canal

2017/2/1

A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies

Cancer medicine

2021/3

Hongkun Wang
Hongkun Wang

H-Index: 21

Deepa Subramaniam
Deepa Subramaniam

H-Index: 17

Outcome of early and intermediate-stage hepatocellular carcinoma (HCC): A single institution experience at MGUH.

2021/1/20

A phase I study of ribociclib plus everolimus in patients with metastatic pancreatic adenocarcinoma refractory to chemotherapy

Journal of Pancreatic Cancer

2020/6/1

Benjamin A Weinberg
Benjamin A Weinberg

H-Index: 11

Hongkun Wang
Hongkun Wang

H-Index: 21

Phase I study of proton therapy in adjuvant pancreatic cancer (PROTON-PANC).

2020/5/20

Hongkun Wang
Hongkun Wang

H-Index: 21

Phase II study of pembrolizumab plus olaparib in the treatment of patients with advanced cholangiocarcinoma.

2020/5/20

Hongkun Wang
Hongkun Wang

H-Index: 21

John Marshall
John Marshall

H-Index: 3

Prophylactic gabapentin results in dramatic reduction of narcotic utilization in head and neck cancer patients undergoing radiotherapy

International Journal of Radiation Oncology, Biology, Physics

2020/4/1

Hongkun Wang
Hongkun Wang

H-Index: 21

A comparison study of the intratumoral microbiome in younger verses older-onset colorectal cancer (COSMO CRC).

2020/2/1

Phase II study of fluorouracil (FU), leucovorin (LV), and nanoliposomal irinotecan (nal-IRI) in previously treated advanced biliary tract cancer (NAPOLI-2).

2020/2/1

Hongkun Wang
Hongkun Wang

H-Index: 21

A minimal family of sub-bases

Hacettepe Journal of Mathematics and Statistics

2020/1/1

Ibrutinib and venetoclax in relapsed and refractory follicular lymphoma

2020/11/5

Granular matrix method of attribute reduction in formal contexts

Soft Computing

2020/11

Jinjin Li
Jinjin Li

H-Index: 22

Hongkun Wang
Hongkun Wang

H-Index: 21

A phase I/II study of veliparib (ABT-888) in combination with 5-fluorouracil and oxaliplatin in patients with metastatic pancreatic cancer

Clinical Cancer Research

2020/10/1

Hongkun Wang
Hongkun Wang

H-Index: 21

Benjamin A Weinberg
Benjamin A Weinberg

H-Index: 11

Abstract CT116: A phase I study of ribociclib plus everolimus in patients with metastatic pancreatic adenocarcinoma refractory to chemotherapy

Cancer Research

2020/8/15

Hongkun Wang
Hongkun Wang

H-Index: 21

See List of Professors in Hongkun Wang University(Georgetown University)